{"database": "lobbying", "table": "lobbying_activities", "rows": [[3335710, "9646ca3c-0b2b-4a81-be7c-28310daf346c", "Q1", "FORBES-TATE", 400976792, "NOVARTIS, INC.", 2025, "first_quarter", "CPT", "Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2025-04-15T18:03:00-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3335710"], "units": {}, "query_ms": 7.185789989307523, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}